Table 5.
Injury characteristics and outcome in operative and non-operative management
| Non-operative (n = 198) | Operative (n = 59) |
P | |
|---|---|---|---|
| Age; mean±SD | 31±12 | 32±16 | 0.74 |
| Gender (male) | 83.5% | 86.4% | 0.70 |
| Glasgow coma scale < 8 | 37 (18.7%) | 11 (19.3%) | 0.91 |
| Injury severity score | 17(4–59) | 17(5–50) | 0.13 |
| Systolic blood pressure < 90 mmHg | 15 (7.6%) | 7 (12.3%) | 0.27 |
| Injury severity score | 18.9 ± 11.0 | 22.0 ± 12.4 | 0.11 |
| Splenic injury | 19 (9.6%) | 9 (15.3%) | 0.22 |
| Kidney injury | 13 (6.6%) | 6 (10.2%) | 0.35 |
| Pelvic injury | 34 (17.2%) | 13 (22.0%) | 0.39 |
| Liver grade (I-III) AAST | 190 (96.0%) | 48 (81.4%) | 0.001 |
| Liver grade (IV-V) AAST | 8 (4.0%) | 11 (18.6%) | |
| FAST | 52(29.5%) | 29(53.7%) | 0.001 |
| CT Abdomen | 137(69.2%) | 40(67.8%) | 0.84 |
| WSES classification | 0.03 for all | ||
| I | 147(74%) | 27(46%) | |
| II | 43(22%) | 7 (12%) | |
| III | 8 (4%) | 6 (10%) | |
| IV | – | 19(32%) | |
| Medications | |||
| Tranexamic acid | 4(3.1%) | 1(2.8%) | 0.91 |
| Factor VII | 10(7.8%) | 12(28.6%) | 0.001 |
| Fibrinogen | 19(14.5%) | 17(38.6%) | 0.001 |
| Inotropes | 19(15.2%) | 14(40%) | 0.001 |
| Blood transfusion | 36 (18.2%) | 34 (57.6%) | 0.001 |
| Hospital length of stay; median and range | 7 (1–323) | 13.5 (1–277) | 0.23 |
| TICU stay (days);median and range | 3(1–41) | 7(1–39) | 0.01 |
| Hospital mortality | 13 (6.6%) | 7 (12.1%) | 0.17 |